Today’s Top Story
Study compares costs of THA versus nonsurgical management based on BMI
Total hip arthroplasty (THA) may be more cost-effective than nonoperative management (NM) regardless of patients’ body mass index (BMI), according to a long-term study published online in The Journal of Arthroplasty. Researchers used a state-transition Markov model that included direct medical costs, but not indirect societal costs, to compare the THA and NM cohorts among six BMI groups in patients > 15 years old. The two highest BMI groups had higher incremental costs and quality-adjusted life years (QALY), but THA was still considered cost-effective among these cohorts. The incremental cost-effectiveness ratios (ICER) for the six BMI groups were:
1. normal weight (BMI, 18.5–24.9 kg/m2): $6,043/QALY
2. overweight (25–29.9 kg/m2): $5,770/QALY
3. obese (30–34.9 kg/m2): $5,425/QALY
4. severely obese (35–39.9 kg/m2): $7,382/QALY
5. morbidly obese (40–49.9 kg/m2): $8,338/QALY
6. super obese (≥ 50 kg/m2): $16,651/QALY
With an ICER threshold of $50,000/QALY, researchers said that THA was more cost-effective than NM in 100 percent of normal weight, overweight, obese, severely obese, and morbidly obese simulations, and in 99.95 percent of super obese simulations. Researchers theorized that BMI cutoffs for THA may contribute to unnecessary loss of healthcare access.
Read the study… |